Pages
October is AAC Awareness Month!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-aac-awareness-month
Pulse Survey results – quarter two
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/pulse-survey-results-quarter-two
Inadine – alert on its usage
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/inadine-alert-its-usage
Access to journal articles for DCHS staff
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/access-journal-articles-dchs-staff
Files
Disclosure Ref 2025203 - Insourcing for haematology, histopathology, andor microbiology services.doc
Freedom of information request relating to the insourcing for haematology, histopathology, and/or microbiology services
Pseudonymisation Policy.docx
DCHS Pseudonymisation (De-Identification) Policy
0535 - Anticoagulation Maintenance Referral Form
0535 - Anticoagulation Maintenance Referral Form
0003 - Continuing Health Care Consent and Basic Information Form
0003 - Continuing Health Care Consent and Basic Information Form
0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19 (P69)
0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19
1187 - Enhanced Observation Competency Check List
1187 - Enhanced Observation Competency Check List
L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Information for patients with venous leg ulcers
L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Patient Information Leaflet for patients with venous leg ulcers.
Unopposed declaration - Public - City of Derby.pdf
City of Derby Unopposed Declaration
Datix Managers Incident Reporting Instructions.docx
DCHS Datix managers incident reporting instructions
The Management of Warfarin Therapy for Inpatients Guidelines (G233)
The aim of this guideline is to improve the safety of anticoagulant therapy for inpatients under the care of DCHS by: • Providing an evidence-based algorithm for the initiation of warfarin therapy in atrial fibrillation, including the use of a specific SystmOne template for warfarin management. • Offering an evidence-based algorithm to guide maintenance dosing decisions. • Clarifying the process for communicating follow-up arrangements to primary care teams when a patient is discharged from hospital. • Endorsing the level of competence and training required of clinicians who prescribe warfarin. • Ensuring that the guidance will be built into an audit and review cycle.